Product news from the 06/06/06 News Brief
Bristol-Myers Squibb’s experimental leukemia drug Sprycel should be approved for patients with few, if any, other leukemia treatment options, an ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.